Boston Scientific Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於公司

公司簡介

公司代碼BSX

公司名稱Boston Scientific Corp

上市日期May 19, 1992

CEOMr. Michael F. (Mike) Mahoney

員工數量53000

證券類型Ordinary Share

年結日May 19

公司地址300 Boston Scientific Way

城市MARLBOROUGH

上市交易所NYSE Consolidated

國家United States of America

郵編01752-1234

電話15086834000

網址https://www.bostonscientific.com/en-US/Home.html

公司代碼BSX

上市日期May 19, 1992

CEOMr. Michael F. (Mike) Mahoney

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

2.08K

-58.23%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

--

Mr. Edward J. Ludwig

Lead Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

其他

1.27B

27.32%

地區USD

名稱

營收

佔比

United States

2.96B

63.48%

EMEA (Europe, Middle East and Africa)

846.00M

18.14%

Asia Pacific

701.00M

15.03%

Latin America and Canada

155.00M

3.32%

業務

地區

業務USD

名稱

營收

佔比

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

其他

1.27B

27.32%

股東統計

更新時間: 8月16日週六

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

9.21%

Fidelity Management & Research Company LLC

6.71%

BlackRock Institutional Trust Company, N.A.

5.28%

State Street Global Advisors (US)

4.40%

PRIMECAP Management Company

2.34%

其他

72.06%

持股股東

佔比

The Vanguard Group, Inc.

9.21%

Fidelity Management & Research Company LLC

6.71%

BlackRock Institutional Trust Company, N.A.

5.28%

State Street Global Advisors (US)

4.40%

PRIMECAP Management Company

2.34%

其他

72.06%

股東類型

持股股東

佔比

Investment Advisor

51.04%

Investment Advisor/Hedge Fund

29.03%

Hedge Fund

4.14%

Pension Fund

2.73%

Research Firm

2.53%

Bank and Trust

2.05%

Sovereign Wealth Fund

1.54%

Family Office

0.23%

Private Equity

0.21%

其他

6.51%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

2752

1.39B

93.57%

+165.36K

2025Q1

2744

1.39B

93.81%

-5.31M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

2023Q1

2012

1.36B

94.85%

-23.81M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

133.95M

9.05%

+1.70M

+1.28%

Mar 31, 2025

Fidelity Management & Research Company LLC

117.45M

7.94%

-3.75M

-3.09%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

77.81M

5.26%

+1.08M

+1.41%

Mar 31, 2025

State Street Global Advisors (US)

64.48M

4.36%

+514.79K

+0.80%

Mar 31, 2025

PRIMECAP Management Company

36.50M

2.47%

-432.72K

-1.17%

Mar 31, 2025

Wellington Management Company, LLP

33.20M

2.24%

-2.97M

-8.21%

Mar 31, 2025

Geode Capital Management, L.L.C.

31.80M

2.15%

+1.18M

+3.84%

Mar 31, 2025

Capital World Investors

28.56M

1.93%

+658.82K

+2.36%

Mar 31, 2025

Managed Account Advisors LLC

21.29M

1.44%

+3.60M

+20.36%

Mar 31, 2025

The Bollard Group, LLC

20.49M

1.39%

-242.40K

-1.17%

Mar 31, 2025

持股ETF

更新時間: 9月2日週二

機構名稱

佔比

iShares U.S. Medical Devices ETF

10.54%

Goldman Sachs Future Health Care Equity ETF

8.82%

Invesco Dorsey Wright Healthcare Momentum ETF

4.98%

JPMorgan Healthcare Leaders ETF

4.19%

Global X Aging Population ETF

3.18%

iShares U.S. Healthcare ETF

3.16%

Knowledge Leaders Developed World ETF

3.16%

Proshares Ultra Health Care

3.15%

Bancreek U.S. Large Cap ETF

3.14%

Health Care Select Sector SPDR Fund

3.1%

iShares U.S. Medical Devices ETF

佔比10.54%

Goldman Sachs Future Health Care Equity ETF

佔比8.82%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比4.98%

JPMorgan Healthcare Leaders ETF

佔比4.19%

Global X Aging Population ETF

佔比3.18%

iShares U.S. Healthcare ETF

佔比3.16%

Knowledge Leaders Developed World ETF

佔比3.16%

Proshares Ultra Health Care

佔比3.15%

Bancreek U.S. Large Cap ETF

佔比3.14%

Health Care Select Sector SPDR Fund

佔比3.1%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Boston Scientific Corp

98.180USD

Boston Scientific Corp

98.180

概覽

公司

財務

分析